Centocor
Executive Summary
President David Holveck adds title of chief executive officer, effective Nov. 6. Holveck succeeds Centocor co-founder Hubert Schoemaker as CEO; Schoemaker remains chairman. Formerly president of Centocor's diagnostics division, Holveck was named president and chief operating officer this past April in a management shakeup that followed FDA's request for a second trial of Centocor's antisepsis monoclonal Centoxin ("The Pink Sheet" May 4, T&G-11).